ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2428

Comparative Study of Rheumatoid Arthritis Disease Activity Indices in Two Populations of Meteor Database

Helena Canhão1, Fernando Magalhaes Martins2, Jose Antonio Melo Gomes3, Maria Jose Santos4, Augusto Faustino5, José Antonio Costa6, Cornelia Allaart7, E. Gvozdenovic8, Pedro Machado9, Jaime C. Branco10, João E. Fonseca11 and José Pereira Da-Silva12, 1Av. Prof. Egas Moniz, Hospital Santa Maria, Lisboa, Portugal, 2Portuguese Society of Rheumatology, Lisbon, Portugal, 3Instituto Português de Reumatologia, Lisbon, Portugal, 4Rheumatology, Hospital Garcia de Orta, Almada, Portugal, 5Clínica de Reumatologia de Lisboa, Lisbon, Portugal, 6Rheumatology, Centro Hospitalar do Alto Minho, Hospital de Ponte de Lima, Ponte de Lima, Portugal, 7Rheumatology, Leiden Univ Med Ctr, Leiden, Netherlands, 8Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 9MRC Centre for Neuromuscular Diseases, University College London, London, United Kingdom, 10Rheumatology, Centro Hospitalar de Lisboa Ocidental, Hospital Egas Moniz, Lisboa, Portugal, 11Lisbon Academic Medical Center, Lisbon, Portugal, 12Rheumatology, Hospitais da Universidade de Coimbra, Coimbra, Portugal

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Disease Activity and rheumatoid arthritis, treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects (ACR): Impact of Various Interventions and Therapeutic Approaches

Session Type: Abstract Submissions (ACR)

Background/Purpose

Our aims were to assess disease activity states using DAS28ESR, CDAI and SDAI and to compare their outcomes in two rheumatoid arthritis (RA) populations of METEOR database.

Methods

A total of 24605 visits from 5870 Dutch patients and 20120 visits from 3185 Portuguese patients were analyzed. We also selected and replicated the same analyses in a subset of one random visit per patient. K-statistics and z-tests were applied to assess agreement and differences between groups. The relative contribution of each RA core set measure was determined for the three indices.   

Results

We found significant differences in the distribution of RA disease activity states between Dutch and Portuguese populations when DAS28ESR was used. SDAI and CDAI attenuated those differences. The percentage of Dutch and Portuguese visits classified as “in remission” was very similar with CDAI, SDAI and ACR/EULAR remission criteria. Contrary, using DAS28ESR, a significant higher proportion of Dutch visits was classified in remission. ESR was lower in Dutch visits and this component was determinant for lowering DAS28 scores in this group of patients.

Conclusion

CDAI and SDAI assigned distinct RA activity states when compared to DAS28 in our two populations from METEOR database. Table – Comparing means of the components of the disease activity indices within each disease activity state between Dutch and Portuguese populations

 

 

 

 

 

 

 

 

 

A. DAS28 original

 

 

 

 

 

 

 

 

 

 

Remission

Low

Moderate

High

 

 

 

 

 

 

 

 

 

 

z

p-value

Z

p-value

z

p-value

z

p-value

 

 

 

 

 

 

 

 

 

PGA

6.73

<0.0001

4.49

<0.0001

8.39

<0.0001

5.82

<0.0001

TJC28

6.24

<0.0001

6.84

<0.0001

-2.61

0.0090

-13.61

<0.0001

SJC28

3.65

0.0003

1.94

0.0520

-0.88

0.3791

-5.32

<0.0001

ESR

-14.33

<0.0001

-9.59

<0.0001

-13.41

<0.0001

-3.57

0.0004

DAS28

-7.34

<0.0001

-0.49

0.6245

-7.94

<0.0001

-10.44

<0.0001

 

 

 

 

 

 

 

 

 

B. CDAI

 

 

 

 

 

 

 

 

 

 

Remission

Low

Moderate

High

 

 

 

 

 

 

 

 

 

 

z

p-value

z

p-value

z

p-value

z

p-value

 

 

 

 

 

 

 

 

 

PGA

1.99

0.0465

-3.71

0.0002

4.64

<0.0001

4.40

<0.0001

MDGA

10.63

<0.0001

11.84

<0.0001

10.4

<0.0001

7.75

<0.0001

TJC28

1.37

0.1713

-3.38

0.0007

-7.95

<0.0001

-11.06

<0.0001

SJC28

-4.59

<0.0001

-4.26

<0.0001

-6.11

<0.0001

-5.99

<0.0001

CDAI

5.87

<0.0001

-0.85

0.3949

-2.85

0.0044

-8.76

<0.0001

 

 

 

 

 

 

 

 

 

C. SDAI

 

 

 

 

 

 

 

 

 

 

Remission

Low

Moderate

High

 

 

 

 

 

 

 

 

 

 

z

p-value

z

p-value

z

p-value

z

p-value

 

 

 

 

 

 

 

 

 

PGA

-3.56

0.0004

-1.77

0.0763

4.52

<0.0001

1.67

0.0955

MDGA

3.66

0.0003

9.13

<0.0001

13.58

<0.0001

6.79

<0.0001

TJC28

1.90

0.0575

0.06

0.9515

-0.31

0.7548

-2.37

0.0179

SJC28

-1.91

0.0555

-3.39

0.0007

-5.78

<0.0001

-3.52

0.0004

CRP

-1.54

0.1232

-2.4

0.0162

-7.27

<0.0001

-1.62

0.1050

SDAI

-0.86

0.3912

1.31

0.19

1.22

0.2233

-2.94

0.0033

 

 

Visits = Number of visits (%)     PGA = Patient assessment of disease activity               (100mm)                      TJC28 = 28 tender joint count

SJC28 = 28 swollen joint count                  MDGA = Physician assessment of disease activity (100mm)          CRP = C-reactive protein (mg/l)

ESR = Erythrocyte sedimentation rate (mm/h)              DAS28 = Disease activity score evaluating 28 joints

CDAI = Clinical disease activity index                         SDAI = Simplified disease activity index

z = z-test for equality of two independent means (z>0 if the mean for Dutch group is higher than for Portuguese group)


Disclosure:

H. Canhão,
None;

F. Magalhaes Martins,
None;

J. A. Melo Gomes,
None;

M. J. Santos,
None;

A. Faustino,
None;

J. A. Costa,
None;

C. Allaart,
None;

E. Gvozdenovic,
None;

P. Machado,
None;

J. C. Branco,
None;

J. E. Fonseca,
None;

J. Pereira Da-Silva,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparative-study-of-rheumatoid-arthritis-disease-activity-indices-in-two-populations-of-meteor-database/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology